维蒂斯拉布鲁斯卡纳贝利叶提取物改善血管功能标志物,包括血小板聚合:一个随机,双盲,安慰剂控制的随机试验
Eun-Soo Jung1, Min-Jun Choi1, Su-Jin Jung1
1Clinical Trial Center for Functional Foods, Jeonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk 54907, Republic of Korea; Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.
概括
维蒂斯拉布鲁斯卡纳贝利叶提取物 (HP-01) 补充剂在患有心血管疾病风险因素的人群中显著降低了血小板聚合和缩血压. 这表明HP-01可以改善静血功能并支持心血管健康.
科学领域:
- 心血管研究的心血管研究.
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 血小板聚合是血栓形成和心血管疾病发展的关键因素.
- 初步研究表明,维蒂斯拉布鲁斯卡纳贝利叶提取物 (HP-01) 可能具有心脏保护和抗血栓作用.
研究的目的:
- 研究HP-01补充剂对心血管疾病风险人群血流参数的影响.
- 评估的关键参数包括血小板聚合 (闭合时间),激活的部分血栓形成时间 (aPTT) 和缩血压 (SBP).
主要方法:
- 进行了一项为期12周的随机,双盲,安慰剂对照试验,80名参与者表现出心血管疾病风险因素.
- 参与者接受HP-01 (1800毫克/天) 或安慰剂,每天服用三次.
- 评估的终点包括血小板聚合的变化,外围动脉度指数,血压,前热血素时间,aPTT和脂质配置文件.
主要成果:
- 与安慰剂组相比,HP-01补充剂导致血小板聚合 (闭合时间) 显著减少 (p=0.0252).
- 在HP-01组中观察到aPTT的显著增加 (p=0.0402) 和缩血压 (SBP) 的显著降低 (p=0.0398).
- 在HP-01或安慰剂组中没有报告严重的不良反应.
结论:
- 补充HP-01证明了对心血管健康的潜在益处.
- 提取物似乎可以改善静血功能,并降低患有心血管疾病风险因素的人的血压.
- 进一步研究HP-01作为心血管健康的支持措施是有必要的.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
01:18Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K